 | Up a level |
Journal Article
Cain, Lauren E., Saag, Michael S., Petersen, Maya, May, Margaret T., Ingle, Suzanne M., Logan, Roger, Robins, James M., Abgrall, Sophie, Shepherd, Bryan E., Deeks, Steven G., Gill, M. John, Touloumi, Giota, Vourli, Georgia, Dabis, Francois, Vandenhende, Marie-Anne, Reiss, Peter, van Sighem, Ard, Samji, Hasina 
ORCID: 0000-0002-4555-7609, Hogg, Robert S., Rybniker, Jan, Sabin, Caroline A., Jose, Sophie, del Amo, Julia, Moreno, Santiago ORCID: 0000-0002-2843-1094, Rodriguez, Benigno, Cozzi-Lepri, Alessandro, Boswell, Stephen L., Stephan, Christoph, Perez-Hoyos, Santiago ORCID: 0000-0001-9797-4917, Jarrin, Inma, Guest, Jodie L., Monforte, Antonella D'Arminio, Antinori, Andrea ORCID: 0000-0003-2121-4684, Moore, Richard, Campbell, Colin N. J., Casabona, Jordi, Meyer, Laurence, Seng, Remonie, Phillips, Andrew N., Bucher, Heiner C., Egger, Matthias ORCID: 0000-0001-7462-5132, Mugavero, Michael J., Haubrich, Richard, Geng, Elvin H., Olson, Ashley, Eron, Joseph J., Napravnik, Sonia, Kitahata, Mari M., Van Rompaey, Stephen E., Teira, Ramon, Justice, Amy C., Tate, Janet P., Costagliola, Dominique ORCID: 0000-0003-0765-0869, Sterne, Jonathan A. C. and Hernan, Miguel A.
(2016).
Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.
Int. J. Epidemiol., 45 (6).
S. 2038 - 2050.
OXFORD:
OXFORD UNIV PRESS.
ISSN 1464-3685
Stirrup, Oliver, Sterne, Jonathan, Dunn, David T., Grabmeier-Pfistershammer, Katharina, Papastamopoulos, Vasileios, Vandenhende, Marie-Anne, Wit, Ferdinand, Porter, Kholoud, Gunsenheimer-Bartmeyer, Barbara, Jarrin, Inma, Garcia, Federico ORCID: 0000-0001-7611-781X, Faetkenheuer, Gerd, Obel, Niels, Schultze, Anna, Antinori, Andrea, Ceccherini-Silberstein, Francesca, Mussini, Cristina, Chene, Genevieve, Neesgaard, Bastian, Castagna, Antonella, Kouyos, Roger, De Wit, Stephane, Sonnerbor, Anders, Sabin, Caroline, Merino, Dolores, Barger, Diana and Phillips, Andrew
(2019).
Long-term virological suppression on first-line efavirenz plus tenofovir=emtricitabine/lamivudine for HIV-1.
Aids, 33 (4).
S. 745 - 752.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1473-5571